0.2000USD-8.13%Mkt Cap: 46.63M USDP/E: —Last update: 2026-06-01
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States. …
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap46.63M USD
Enterprise Value157.91M USD
Revenue (TTM)55.54M USD
Gross Profit55.54M USD
Net Income (TTM)-170.37M USD
Revenue/Share0.2410 USD
Last Price0.2000 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees161
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS38341P1021
Valuation
P/E (Trailing)—
P/E (Forward)-2.45
PEG—
EV/EBITDA-0.92
EV/Revenue2.84
P/S0.98
P/B-0.34
EPS (TTM)-0.79
EPS (Forward)-0.09
52W Range
0.16301% of range3.870
52W High3.870 USD
52W Low0.1630 USD
Profitability
Gross Margin100.00%
Oper. Margin-264.62%
EBITDA Margin0.00%
Profit Margin-351.49%
ROE138.78%
ROA-98.91%
Growth
Revenue Growth71.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-171.27M USD
CapEx (TTM)79.00K USD
FCF Margin-175.11%
FCF Yield-208.54%
Net Debt103.72M USD
Net Debt/EBITDA-0.61
Balance Sheet
Debt/Equity-1.65
Current Ratio2.20
Quick Ratio1.92
Book Value/Sh-0.6880 USD
Cash/Share0.4230 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.7 (Hold)
Target (Mean)4.456 USD
Target Range0.2800 USD – 15.00 USD
# Analysts5
Ownership
Shares Out.234.70M
Float227.18M
Insiders3.53%
Institutions72.76%
Short Interest
Short Ratio8.8d
Short % Float18.63%
Short % Out.17.40%
Shares Short40.84M
Short (prev mo.)40.20M
Technical
SMA 500.3452 (-42.1%)
SMA 2001.921 (-89.6%)
Beta2.15
S&P 52W Chg27.94%
Avg Vol (30d)9.76M
Avg Vol (10d)19.84M
Technical Indicators
RSI (14)33.7
MACD-0.0559
MACD Signal-0.0556
MACD Hist.-0.0003
BB Upper0.4221 USD
BB Middle0.2815 USD
BB Lower0.1410 USD
BB Width99.83%
ATR (14)0.0358 USD
Vol Ratio (20d)0.76x